/Lists

Biotech Investors & VC Firms in North America

1593 firms in this list, with a median first check of $500K. 347 of them lead rounds. Generated from verified public data and updated continuously.

Prolog Ventures
ClaytonSeries A$250K – $1M
6 people
6 Dimensions Capital
Grand CaymanSeed–Late Stage
17 people
Cultivian Sandbox Ventures
ChicagoSeed–Late Stage$5M – $15M
8 people
Healthtech Capital
Silicon ValleySeed–Series A
5 people
Virginia Venture Partners
RichmondPre-Seed–Seed$100K
11 people
Flow Capital
TorontoGrowth
2 people
FemHealth Ventures
Short HillsSeed–Series A
10 people
First Spark Ventures, Llc
Menlo ParkPre-Seed–Series A
10 people
Apex Innovative Investments Ventures
VancouverPre-Seed–Seed$250K
9 people
New Rhein Healthcare Investors, LLC
PhiladelphiaSeries B–Late Stage
15 people
Scion Life Sciences
New YorkPre-Seed–Seed$1K – $60M
12 people
CABHI Ventures
TorontoPre-Seed–Series A
11 people
Kaleida Capital
San Diego
14 people
Nimbus Synergies Inc.
VancouverPre-Seed–Series A$250K – $2M
14 people
Propel Bio Partners
Los AngelesSeed–Series A
17 people
Riverfront Ventures, LLC
PittsburghSeed–Series A$250K – $1M
8 people
Tech Council Ventures
SummitSeed–Series B$500K – $3M
8 people
Rogue Insight Capital
MarkhamSeed
2 people
ISA Ventures
Cedar RapidsPre-Seed–Late Stage$25K – $1M
4 people
Bootstrap Venture Partners
Solana BeachSeed–Series A
6 people
Great Circle Ventures
New YorkPre-Seed–Seed
9 people
PureTech Health
Boston
15 people
SustainVC
BostonSeed–Series A$500K – $1M
6 people
Esplanade Ventures
TorontoSeed–Series B
11 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.